Nonadherence to Biologic Therapies in Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nonadherence to Biologic Therapies in Inflammatory Bowel Disease

Published:2018-04-13 Issue:9 Volume:24 Page:2053-2061
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Wentworth Brian J¹,Buerlein Ross C D²,Tuskey Anne G²,Overby M Ashley²,Smolkin Mark E³,Behm Brian W²

Affiliation:

1. Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA

2. Division of Gastroenterology & Hepatology, University of Virginia School of Medicine, Charlottesville, VA

3. Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/article-pdf/24/9/2053/25502311/izy102.pdf

Reference13 articles.

1. The global burden of IBD: from 2015 to 2025;Kaplan;Nat Rev Gastroenterol Hepatol,2015

2. Biological therapies for inflammatory bowel diseases;Rutgeerts;Gastroenterology,2009

3. Adherence rates with infliximab therapy in crohn’s disease;Kane;Aliment Pharmacol Ther,2006

4. Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease;Selinger;Inflamm Bowel Dis,2013

5. Adherence to anti-TNF therapy in inflammatory bowel diseases: a systematic review;Lopez;Inflamm Bowel Dis,2013

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

2. Adherence to infliximab treatment in patients with immune-mediated inflammatory diseases from a Referral Center in Brazil: A cohort study;2024-06-13

3. Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2024-04-23

4. Tofacitinib and peficitinib inhibitors of Janus kinase for autoimmune disease treatment: a quantum biochemistry approach;Physical Chemistry Chemical Physics;2024

5. 3D printed infliximab suppositories for rectal biologic delivery;International Journal of Pharmaceutics: X;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3